Search research articles
Contact Us
Filters
Showing results (71-80 of 117) with videos related to
Page
of 12
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
February 4, 2022
mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children
Bethany Girard, Joanne E Tomassini, Weiping Deng, et al.
The New England Journal of Medicine
|
November 23, 2022
Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination
Spyros Chalkias, Jing Feng, Xing Chen, et al.
Journal of Clinical Lipidology
|
December 3, 2010
Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients
JoAnne M Foody, Shiva G Sajjan, X Henry Hu, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
A novel antiviral agent which inhibits the endonuclease of influenza viruses
J E Tomassini, M E Davies, J C Hastings, et al.
Journal of Clinical Lipidology
|
March 6, 2012
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction
Peter P Toth, Christie M Ballantyne, Michael H Davidson, et al.
The New England Journal of Medicine
|
September 9, 2022
Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination
Xiaoying Shen, Spyros Chalkias, Jing Feng, et al.
The Journal of Biological Chemistry
|
February 5, 1990
Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells
J H Condra, V V Sardana, J E Tomassini, et al.
Journal of Clinical Lipidology
|
July 30, 2013
Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome
Jennifer G Robinson, Christie M Ballantyne, Willa A Hsueh, et al.
Journal of Clinical Lipidology
|
February 18, 2014
Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease
Peter P Toth, Joanne M Foody, Joanne E Tomassini, et al.
Atherosclerosis
|
August 6, 2016
Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice
Alberico L Catapano, Dominik Lautsch, Lale Tokgözoglu, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 117) with videos related to
Sort By:
Page
of 12
Medrxiv : the Preprint Server for Health Sciences
|
February 4, 2022
mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children
Bethany Girard, Joanne E Tomassini, Weiping Deng, et al.
The New England Journal of Medicine
|
November 23, 2022
Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination
Spyros Chalkias, Jing Feng, Xing Chen, et al.
Journal of Clinical Lipidology
|
December 3, 2010
Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients
JoAnne M Foody, Shiva G Sajjan, X Henry Hu, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
A novel antiviral agent which inhibits the endonuclease of influenza viruses
J E Tomassini, M E Davies, J C Hastings, et al.
Journal of Clinical Lipidology
|
March 6, 2012
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction
Peter P Toth, Christie M Ballantyne, Michael H Davidson, et al.
The New England Journal of Medicine
|
September 9, 2022
Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination
Xiaoying Shen, Spyros Chalkias, Jing Feng, et al.
The Journal of Biological Chemistry
|
February 5, 1990
Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells
J H Condra, V V Sardana, J E Tomassini, et al.
Journal of Clinical Lipidology
|
July 30, 2013
Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome
Jennifer G Robinson, Christie M Ballantyne, Willa A Hsueh, et al.
Journal of Clinical Lipidology
|
February 18, 2014
Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease
Peter P Toth, Joanne M Foody, Joanne E Tomassini, et al.
Atherosclerosis
|
August 6, 2016
Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice
Alberico L Catapano, Dominik Lautsch, Lale Tokgözoglu, et al.
Page
of 12